| Product NDC: | 0023-9201 |
| Proprietary Name: | ELESTAT |
| Non Proprietary Name: | epinastine hydrochloride |
| Active Ingredient(s): | .5 mg/mL & nbsp; epinastine hydrochloride |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0023-9201 |
| Labeler Name: | Allergan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021565 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20040119 |
| Package NDC: | 0023-9201-05 |
| Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (0023-9201-05) > 5 mL in 1 BOTTLE, DROPPER |
| NDC Code | 0023-9201-05 |
| Proprietary Name | ELESTAT |
| Package Description | 1 BOTTLE, DROPPER in 1 CARTON (0023-9201-05) > 5 mL in 1 BOTTLE, DROPPER |
| Product NDC | 0023-9201 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | epinastine hydrochloride |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20040119 |
| Marketing Category Name | NDA |
| Labeler Name | Allergan, Inc. |
| Substance Name | EPINASTINE HYDROCHLORIDE |
| Strength Number | .5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic Agonists [MoA],Adrenergic Receptor Agonist [EPC],Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |